Market Cap 57.52B
Revenue (ttm) 293.96B
Net Income (ttm) 1.51B
EPS (ttm) N/A
PE Ratio 19.77
Forward PE 18.77
Profit Margin 0.51%
Debt to Equity Ratio 6.66
Volume 3,544,100
Avg Vol 1,679,062
Day's Range N/A - N/A
Shares Out 193.82M
Stochastic %K 73%
Beta 0.58
Analysts Strong Sell
Price Target $324.00

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
harmongreg
harmongreg Jun. 15 at 3:44 PM
5 Trade Ideas for Monday: Antero, Cencora, CVS, J&J and Marathon Petroleum $AR $COR $CVS $JNJ $MPC https://dragonflycap.com/5-trade-ideas-for-monday-antero-cencora-cvs-jj-and-marathon-petroleum/
0 · Reply
QuiverQuant
QuiverQuant Jun. 6 at 2:57 PM
New Analyst Forecast: $COR Given 'Overweight' Rating Read more on $COR: https://www.quiverquant.com/news/New+Analyst+Forecast%3A+%24COR+Given+%27Overweight%27+Rating
0 · Reply
erevnon
erevnon Jun. 3 at 2:43 PM
Wells Fargo upgrades Cencora $COR from Equal-Weight to Overweight and raises the price target from $274 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
trading_momentum
trading_momentum Jun. 3 at 1:56 PM
Analyst Upgrades: Deutsche Bank raised its S&P 500 year-end target to 6,550 from 6,150, citing lower tariff-related earnings drag. Wells Fargo upgraded Cardinal Health $CAH and Cencora $COR to BUY with price targets of $179 and $337, respectively. Cantor Fitzgerald initiated Salesforce $CRM as BUY with a $325 target., Market Movers: U.S.-listed shares of Li Auto $LI rose 6% premarket, tracking a rebound in domestic stock performance.
0 · Reply
JarvisFlow
JarvisFlow Jun. 3 at 1:00 PM
Wells Fargo updates rating for Cencora ( $COR ) to Overweight, target set at 274 → 337.
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 2:16 PM
$COR up 29.4% YTD—what's driving this rally? 🚀 🌟 Strong U.S. Healthcare Solutions performance 💊 Specialty & GLP-1 medications boost growth 📈 Adjusted EPS projected to rise 14-16% in fiscal 2025 See why Cencora is a Zacks Rank #2 Buy 👉 https://www.zacks.com/commentary/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-body&ADID=SYND_STOCKTWITS_TWEET_2_2479450_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 12:54 PM
$COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. Read the full story here: https://www.zacks.com/stock/news/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479450_TEASER
0 · Reply
TradeInYourJob
TradeInYourJob May. 30 at 12:33 AM
$COR Sell Signal on the weekly timeframe CCI and negative divergence in the onbalance volume.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 21 at 11:31 AM
Is $COR maintaining its trajectory within the projected Post-Earnings Announcement Drift (PEAD) cone? Monitoring whether the stock's price action remains within this forecasted range helps assess the accuracy of the earnings-based predictive model and potential deviations in momentum. #stocks #trading #investing
0 · Reply
Latest News on COR
Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 24 days ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors


Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:55 AM EDT - 6 weeks ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript


Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 6 weeks ago

Cencora Reports Fiscal 2025 Second Quarter Results


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 2 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM


Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 26, 2025, 11:00 AM EST - 4 months ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake


Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 11:40 AM EST - 4 months ago

Cencora (COR) Q1 2025 Earnings Call Transcript


Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 4 months ago

Cencora raises 2025 profit forecast on specialty drug demand


Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 4 months ago

Cencora Reports Fiscal 2025 First Quarter Results


Cencora raises annual profit forecast

Jan 2, 2025, 4:23 PM EST - 6 months ago

Cencora raises annual profit forecast


Cencora Completes Acquisition of Retina Consultants of America

Jan 2, 2025, 4:15 PM EST - 6 months ago

Cencora Completes Acquisition of Retina Consultants of America


Cencora Closes $1.8 Billion Senior Notes Offering

Dec 9, 2024, 4:15 PM EST - 6 months ago

Cencora Closes $1.8 Billion Senior Notes Offering


Cencora: Competitive Advantages Defined

Dec 5, 2024, 10:26 AM EST - 7 months ago

Cencora: Competitive Advantages Defined


Cencora to Host Inaugural Product Showcase

Nov 26, 2024, 8:30 AM EST - 7 months ago

Cencora to Host Inaugural Product Showcase


Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Nov 6, 2024, 10:56 AM EST - 8 months ago

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript


Cencora to buy Retina Consultants of America for $4.6 bln

Nov 6, 2024, 6:54 AM EST - 8 months ago

Cencora to buy Retina Consultants of America for $4.6 bln


Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Nov 6, 2024, 6:35 AM EST - 8 months ago

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results


Dividend Aristocrats Of The Future - Part 3

Nov 1, 2024, 4:42 PM EDT - 8 months ago

Dividend Aristocrats Of The Future - Part 3

AIZ COST CSX DUK K RSG SRE


Cencora Elects Frank Clyburn to Its Board of Directors

Aug 15, 2024, 7:30 AM EDT - 11 months ago

Cencora Elects Frank Clyburn to Its Board of Directors


Pharma giant Cencora is alerting millions about its data breach

Aug 2, 2024, 10:45 AM EDT - 11 months ago

Pharma giant Cencora is alerting millions about its data breach


Walgreens further reduces stake in Cencora

Aug 1, 2024, 6:20 PM EDT - 11 months ago

Walgreens further reduces stake in Cencora

WBA


Cencora says additional data stolen in February cyberattack

Jul 31, 2024, 6:14 PM EDT - 11 months ago

Cencora says additional data stolen in February cyberattack


Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript

Jul 31, 2024, 11:12 AM EDT - 11 months ago

Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript


Cencora Reports Fiscal 2024 Third Quarter Results

Jul 31, 2024, 6:30 AM EDT - 11 months ago

Cencora Reports Fiscal 2024 Third Quarter Results


Cencora: Long-Term Compounder With Mouth-Watering Economics

Jun 24, 2024, 12:20 PM EDT - 1 year ago

Cencora: Long-Term Compounder With Mouth-Watering Economics


PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
harmongreg
harmongreg Jun. 15 at 3:44 PM
5 Trade Ideas for Monday: Antero, Cencora, CVS, J&J and Marathon Petroleum $AR $COR $CVS $JNJ $MPC https://dragonflycap.com/5-trade-ideas-for-monday-antero-cencora-cvs-jj-and-marathon-petroleum/
0 · Reply
QuiverQuant
QuiverQuant Jun. 6 at 2:57 PM
New Analyst Forecast: $COR Given 'Overweight' Rating Read more on $COR: https://www.quiverquant.com/news/New+Analyst+Forecast%3A+%24COR+Given+%27Overweight%27+Rating
0 · Reply
erevnon
erevnon Jun. 3 at 2:43 PM
Wells Fargo upgrades Cencora $COR from Equal-Weight to Overweight and raises the price target from $274 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
trading_momentum
trading_momentum Jun. 3 at 1:56 PM
Analyst Upgrades: Deutsche Bank raised its S&P 500 year-end target to 6,550 from 6,150, citing lower tariff-related earnings drag. Wells Fargo upgraded Cardinal Health $CAH and Cencora $COR to BUY with price targets of $179 and $337, respectively. Cantor Fitzgerald initiated Salesforce $CRM as BUY with a $325 target., Market Movers: U.S.-listed shares of Li Auto $LI rose 6% premarket, tracking a rebound in domestic stock performance.
0 · Reply
JarvisFlow
JarvisFlow Jun. 3 at 1:00 PM
Wells Fargo updates rating for Cencora ( $COR ) to Overweight, target set at 274 → 337.
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 2:16 PM
$COR up 29.4% YTD—what's driving this rally? 🚀 🌟 Strong U.S. Healthcare Solutions performance 💊 Specialty & GLP-1 medications boost growth 📈 Adjusted EPS projected to rise 14-16% in fiscal 2025 See why Cencora is a Zacks Rank #2 Buy 👉 https://www.zacks.com/commentary/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-body&ADID=SYND_STOCKTWITS_TWEET_2_2479450_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 12:54 PM
$COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. Read the full story here: https://www.zacks.com/stock/news/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479450_TEASER
0 · Reply
TradeInYourJob
TradeInYourJob May. 30 at 12:33 AM
$COR Sell Signal on the weekly timeframe CCI and negative divergence in the onbalance volume.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 21 at 11:31 AM
Is $COR maintaining its trajectory within the projected Post-Earnings Announcement Drift (PEAD) cone? Monitoring whether the stock's price action remains within this forecasted range helps assess the accuracy of the earnings-based predictive model and potential deviations in momentum. #stocks #trading #investing
0 · Reply
NxtBgThng
NxtBgThng May. 17 at 2:19 AM
$OTLK started buying $COR when Outlook hired them to market lytenava as buyout rumors were swirling. Has worked out well.
0 · Reply
CLiZzY
CLiZzY May. 15 at 2:53 PM
$COR looks pretty solid
0 · Reply
IN0V8
IN0V8 May. 12 at 4:50 PM
$COR JP Morgan raises target price to $326 from $301
0 · Reply
DonCorleone77
DonCorleone77 May. 12 at 2:58 PM
$UNH $CI $CAH $COR $MCK Trump says will 'cut out middlemen' to reduce drug prices President Donald Trump made the comment while speaking from the White House.
0 · Reply
1986iamwallstreet
1986iamwallstreet May. 12 at 2:26 PM
$COR bleeding 🩸
0 · Reply
1986iamwallstreet
1986iamwallstreet May. 12 at 1:36 PM
$COR will Go below 250…..
0 · Reply
1986iamwallstreet
1986iamwallstreet May. 12 at 1:32 PM
$COR flushing
0 · Reply
abman54
abman54 May. 12 at 9:53 AM
$COR dang bought the wrong day…hopefully it recovers with the market rally
0 · Reply
WallStJesus
WallStJesus May. 9 at 2:47 PM
$COR JUNE BULL FLOW ..
0 · Reply
PUMPIT613
PUMPIT613 May. 9 at 11:26 AM
$COR this should explode today!!!!
0 · Reply
PUMPIT613
PUMPIT613 May. 8 at 7:54 PM
$COR way too oversold, let’s get this party started!!!
0 · Reply
PUMPIT613
PUMPIT613 May. 8 at 7:52 PM
$COR GO BIG GREEN CANDLE!!!!!
0 · Reply